Who is the next for aortic valve implantation? Present and future indications

Abstract

Aortic valve stenosis (AS) represents the most prevalent valvular defect worldwide. It is a progressive disease with a long latency interval and a poor prognosis after symptoms present. According to current European Society of Cardiology guidelines, transcatheter aortic valve implantation (TAVI) is recommended in all patients with severe symptomatic AS and a predicted survival longer than one year, who are not suitable for surgical valve replacement. Despite these recommendations, several studies over the past few years suggest extending these indications towards lower risk AS populations. Otherwise, current available operative risk scores such as Society of Thoracic Surgeons score and EuroSCORE, may offer an incomplete risk assessment; in this setting, the Heart Team plays a crucial role in defining the most appropriate therapeutic strategy in patients with AS. In this review, we aim to discuss the current and future indications for TAVI, analyzing available literature according to patients’ profile risk (high/mid/low risk) and other specific conditions (valve-in-valve, bicuspid valve and pure aortic regurgitation).

Keywords

Aortic valve implantation / aortic stenosis / structural valve intervention / bicuspid valve / valve-in-valve

References

[1] Ross JJr.Aortic stenosis.Circulation1968;38:61-7

[2] Cribier A,Bash A,Tron C,Derumeaux G,Laborde F.Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description.Circulation2002;106:3006-8

[3] Baumgartner H,Bax JJ,Hamm C,Iung B,Lansac E,Rosenhek R,Tornos Mas P,Walther T,Windecker S.2017 ESC/EACTS Guidelines for the management of valvular heart disease.Eur Heart J2017;38:2739-91

[4] Duncan A,Banya W,Marlee D,Mullen M,Spyt T.Long-term outcomes after transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis: the UK. Transcatheter Aortic Valve Implantation Registry..JACC Cardiovasc Interv2015;8:645-53

[5] Gilard M,Iung B,Chevreul K,Leprince P,Lievre M,Teiger E,Himbert D,Carrié D,Cribier A,Sudre A,Collet F,Meneveau N,Caussin C,Boschat J,Collart F,Delpine S,Favereau X,Doisy V,Gommeaux A,Bourlon F,Van Belle E.Registry of transcatheter aortic-valve implantation in high-risk patients.N Engl J Med2012;366:1705-15

[6] Walther T,Schuler G,Kötting J,Mudra H,Cremer J,Lange R,Mohr FW.Perioperative results and complications in 15,964 transcatheter aortic valve replacements: prospective data from the GARY registry.J Am Coll Cardiol2015;65:2173-80

[7] Popma JJ,Reardon MJ,Kleiman NS,Hermiller JJr,Harrison JK,Diez J,Schreiber T,Conte J,Deeb GM,Serruys PW,Oh JK.Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.J Am Coll Cardiol2014;63:1972-81

[8] Smith CR,Mack MJ,Moses JW,Tuzcu EM,Fontana GP,Williams M,Kapadia S,Thourani VH,Pichard AD,Herrmann HC,Anderson WN,Pocock SJ.Transcatheter versus surgical aortic-valve replacement in high-risk patients.N Engl J Med2011;364:2187-98

[9] Adams DH,Reardon MJ,Coselli JS,Gleason TG,Hermiller JJr,Chetcuti S,Merhi W,Tadros P,Petrossian G,Harrison JK,Maini B,Chenoweth S.Transcatheter aortic-valve replacement with a self-expanding prosthesis..N Engl J Med2014;370:1790-8

[10] Otto C,Alexander KP,Desai MY,Lee JC,Vassileva CM.2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.J Am Coll Cardiol2017;69:1313-46

[11] Kirtane AJ.The Placement of Aortic Transcatheter Valve (PARTNER) trial: clinical trials.Circulation2012;125:3229-32

[12] Florath I,Boening A,Ennker J.Aortic valve replacement in octogenarians: identification of high-risk patients.Eur J Cardiothorac Surg2010;37:1304-10

[13] Dewey TM,Ryan WH,Prince SL.Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement.J Thorac Cardiovasc Surg2008;135:180-7

[14] Vahanian A,Al-Attar N,Bax J,Cribier A,Fournial G,Kovac J,Maisano F,Mohr FW,Pierard L,Schofer J,Tuzcu M,von Segesser LK.Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI).Eur J Cardiothorac Surg2008;34:1-8

[15] Roques F,Michel P.Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program.J Heart Valve Dis2001;10:572-7; discussion 577-8

[16] Ferguson TBJr,Edwards FH,Shroyer AL,Anderson RP.The STS National Database: current changes and challenges for the new millennium Committee to Establish a National Database in Cardiothoracic Surgery, The Society of Thoracic Surgeons..Ann Thoracic Surg2000;69:680-91

[17] Green P,Genereux P,Paradis JM,Hawkey M,Kirtane AJ,Moses JW,Smith CR.The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience.JACC Cardiovasc Interv2012;5:974-81 PMCID:PMC3717525

[18] Anand A,Visvanathan A,Cowell J,Shenkin S.The relationship between preoperative frailty and outcomes following transcatheter aortic valve implantation: a systematic review and meta-analysis.Eur Heart J Qual Care Clin Outcomes2017;3:123-32

[19] Nishimura RA,Bonow RO,Erwin JP3rd,O'Gara PT,Skubas NJ,Sundt TM3rd.2014 AHA/ACC Guideline for the management of patients with valvular heart disease: executive summary; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Circulation2014;129:e650

[20] Leon MB,Mack M,Moses JW,Tuzcu EM,Fontana GP,Brown DL,Guyton RA,Bavaria JE,Douglas PS,Akin JJ,Wang D.Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.N Engl J Med2010;363:1597-607

[21] Shroyer AL,Peterson ED,DeLong ER,Ferguson TBJr,Edwards FH.The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models.Ann Thorac Surg2003;75:30

[22] Mack MJ,Smith CR,Moses JW,Webb JG,Anderson WN,Kodali SK,Fontana GP,Bavaria J,Thourani VH,Pichard A,Brown DL,Akin J,Svensson LG.5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial.Lancet2015;385:2477-84

[23] Kapadia SR,Makkar RR,Svensson LG,Webb JG,Douglas PS,Babaliaros VC,Szeto WY,Williams MR,Miller DC,Akin JJ,Smith CR.5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial.Lancet2015;385:2485-91

[24] Thomas M,Walther T,Lefèvre T,Eggebrecht H,Michev I,Anderson WN.Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.Circulation2010;122:62-9

[25] Moat NE,de Belder MA,Cunningham AD,Thomas M,Spyt T,Wendler O,Davies SW,Blackman DJ,Brecker SJ,Daniel T,Mullen MJ.Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the UK. aortic valve implantation (United Kingdom Transcatheter Aortic Valve Implantation) Registry..J Am Coll Cardiol2011;58:2130-8

[26] Brown DL.Expanding indications for TAVR: The preferred procedure in intermediate-risk patients?.Cleve Clinic J Med2017;84:e10-4

[27] Stähli BE,Lüscher TF,Mikulicic F,Bühler I,Altwegg L,Grünenfelder J,Corti R.Early and late mortality in patients undergoing transcatheter aortic valve implantation: comparison of the Novel EuroSCORE II with Established Risk Scores.Cardiology2013;126:15-23

[28] Leon MB,Mack MJ,Svensson LG,Thourani VH,Craig Miller D,Doshi D,Pichard AD,Dewey T,Szeto WY,Kereiakes D,Greason KL,Hodson RW,Trento A,Fearon WF,Hahn RT,Anderson WN,Webb JG.Transcatheter or surgical aortic-valve replacement in intermediate-risk patients.N Engl J Med2016;374:1609-20

[29] Reardon MJ,Popma JJ,Søndergaard L,Adams DH,Maini B,Chetcuti S,Heiser J,Merhi W,Olsen PS,Williams M,Yakubov SJ,Makkar R,Conte J,Nguyen H,Mugglin AS,Kappetein AP.Surgical or transcatheter aortic-valve replacement in intermediate-risk patients.N Engl J Med2017;376:1321-31

[30] Thyregod HG,Ihlemann N,Kjeldsen BJ,Chang Y,Engstrøm T,Hansen PB,Olsen PS.Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the All-Comers NOTION Randomized Clinical Trial.J Am Coll Cardiol2015;65:2184-94

[31] Thyregod HG.Five-year outcomes from the All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial in patients with severe aortic valve stenosis..ACC Annual Congress;2018;

[32] Wenaweser P,Schwander S,Huber C,Gloekler S,Meier B,Carrel T.Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation.Eur Heart J2013;34:1894-905

[33] Tamburino C,D'Errigo P,Onorati P,Santini F,Santoro G,Grossi C.1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: results from the Italian OBSERVANT Study.J Am Coll Cardiol2015;66:804-12

[34] Tarantini G,Gers BJ.Transcatheter aortic valve implantation in lower-risk patients: what is the perspective?.Eur Heart J2018;39:1-12

[35] Thourani VH,Szeto WY,Blackstone EH,Semple M,Makkar RR,Bavaria JE,Maniar HS,Smith CR,Corso PJ,Craig Miller D,Kapadia S,Suri RM,Hahn RT,Alu MC,Mack MJ.Outcomes in 937 intermediate-risk patients undergoing surgical aortic valve replacement in PARTNER-2A.Ann Thorac Surg2018;105:1322-9

[36] Garcia S,Mbai M,Oestreich B,Adabag S.Outcomes of intermediate-risk patients treated with transcatheter and surgical aortic valve replacement in the Veterans Affairs Healthcare System: a single center 20-year experience.Catheter Cardiovasc Interv2018;

[37] Tarantini G,Napodano M,Gerosa G.Valvular leak after transcatheter aortic valve implantation: a clinician update on epidemiology, pathophysiology and clinical implications.Am J Cardiovasc Dis2011;1:312-20 PMCID:PMC3253519

[38] Bauer T,Sievert H,Hambrecht R,Hauptmann KE,Gerckens U,Zeymer U.Comparison of the effectiveness of transcatheter aortic valve implantation in patients with stenotic bicuspid versus tricuspid aortic valves (from the German TAVI Registry).Am J Cardiol2014;113:518-21

[39] Phan K,Phan S,Qian P.Transcatheter aortic valve implantation (aortic valve implantation) in patients with bicuspid aortic valve stenosis--systematic review and meta-analysis.Heart Lung Circ2015;24:649-59

[40] Sannino A,Stoler RC,Mack MJ.Comparison of efficacy and safety of transcatheter aortic valve implantation in patients with bicuspid versus tricuspid aortic valves.Am J Cardiol2017;120:1601-6

[41] Praz F,Huber C,Wenaweser P.Expanding indications of transcatheter heart valve interventions.J Am Coll Cardiol Intv2015;8:1777-96

[42] Yoon SH,Bleiziffer S,Fiorina C,Yzeiraj E,Tchetche D,Fujita B,Deutsch MA,Deuschl F,De Biase C,Dhoble A,Ferrari E,Vollema EM,Giannini C,Kong WKF,Jimenez Diaz VA,Kaneko H,Makar M,Hengstenberg C,Vincent F,Nombela-Franco L,Tarantini G,Ensminger SM,Petronio AS,De Marco F,Van Mieghem NM,Kuck KH,Kar S,Delgado V,Nietlispach F,Schofer J,Bax JJ,Latib A.Transcatheter aortic valve replacement in pure native aortic valve regurgitation.J Am Coll Cardiol2017;70:2752-63

[43] Franzone A,Siontis GC,Stortecky S,Roost E,Windecker S.Transcatheter aortic valve replacement for the treatment of pure native aortic valve regurgitation: a systematic review.JACC Cardiovasc Interv2016;9:2308-17

[44] Sawaya FJ,Seiffert M,Codner P,Latib A,Rodés-Cabau J,Spaziano M,Biasco L,Savontaus M,Chan J,Sievert H,Lefèvre T,Mangieri A,Kornowski R,Bleiziffer S,De Backer O.Safety and efficacy of transcatheter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses: results from an International Registry Study.JACC Cardiovasc Interv2017;10:1048-56

[45] Brown JM,Wu C,Griffith BP.Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database.J Thorac Cardiovasc Surg2009;137:82-90

[46] Ussia GP,Petronio AS,Ettori F,Violini R,Santoro G,Bedogni F,Marzocchi A,De Carlo M,Fiorina C,Antoniucci D,Capodanno D.Transcatheter aortic valve implantation: 3-year outcomes of selfexpanding CoreValve prosthesis.Eur Heart J2012;33:969-76

[47] Rode ́s-Cabau J,Doyle D.Transcatheter valve- in-valve implantation for the treatment of stentless aortic valve dysfunction.J Thorac Cardiovasc Surg2010;140:246-8

[48] Eggebrecht H,Treede H,Babin-Ebell J,Mo ̈llmann H,Carrel T,Lange P,Erbel R,Thielmann M.Valve-in-valve transcatheter aortic valve implantation for degenerated bioprosthetic heart valves.JACC Cardiovasc Interv2011;4:1218-27

[49] David TE,Armstrong S,Cohen G.Late results of heart valve replacement with the Hancock II bioprosthesis.J Thorac Cardiovasc Surg2001;121:268-77

[50] Maganti M,Armstrong S,Scully HE.Redo valvular surgery in elderly patients.Ann Thorac Surg2009;87:521-5

[51] Dvir D,Brecker S,Hildick-Smith D,Descoutures F,Moat NE,Napodano M,Lefevre T,Nissen H,Roy D,Segev A,Fiorina C,Tchetche D,De Marco F,Laborde JC.Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry.Circulation2012;126:2335-44

[52] Seiffert M,Baldus S,Schirmer J,Koschyk D,Reichenspurner H.Impact of patient- prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated bioprostheses.J Thorac Cardiovasc Surg2011;143:617-24

[53] Gurvitch R,Bedogni F.Coronary obstruction following transcatheter aortic valve-in-valve implantation for failed surgical bioprostheses.Catheter Cardiovasc Interv2011;77:439-44